Brief: Apyx Medical Announces Results Of U.S. Ide Clinical Study Evaluating The Use Of Renuvion To Improve Appearance Of Lax Skin

Apyx Medical

08/07/2022 20:54

July 8 (Reuters) - Apyx Medical Corp  APYX.O :
    * APYX MEDICAL CORPORATION ANNOUNCES RESULTS OF THE U.S. IDE
CLINICAL STUDY EVALUATING THE USE OF RENUVION TO IMPROVE THE
APPEARANCE OF LAX SKIN IN THE NECK AND SUBMENTAL REGION
    * APYX MEDICAL CORP - IN PHASE II OF PROSPECTIVE,
MULTI-CENTER
TRIAL WITH 65 SUBJECTS, PRIMARY EFFECTIVENESS ENDPOINT OF STUDY
WAS MET
    * APYX MEDICAL CORP - ADDITIONAL EFFECTIVENESS ENDPOINTS IN
STUDY
ALSO DEMONSTRATED SUCCESS
    * APYX MEDICAL CORP - THERE WERE NO SERIOUS ADVERSE EVENTS
REPORTED IN STUDY THAT WERE RELATED TO RENUVION DEVICE OR STUDY
PROCEDURE
    * APYX MEDICAL CORP - PRIMARY SAFETY ENDPOINT OF STUDY WAS
ALSO
MET

Source text for Eikon:  ID:nBw30rrNa 
Further company coverage:  APYX.O 

 ((Reuters.Briefs@thomsonreuters.com;))